Journal of Cancer Research and Clinical Oncology (JCRCO)

Journal of Cancer Research and Clinical Oncology is a leading international peer-reviewed medical journal dedicated to publishing significant advances in experimental and clinical oncology. The journal serves as a platform for oncologists, cancer researchers, clinicians, and healthcare professionals to share innovative findings that contribute to the understanding, diagnosis, treatment, and prevention of cancer. It publishes original research articles, reviews, editorials, rapid communications, and letters addressing important developments across the entire spectrum of oncology. The journal emphasizes translational research that bridges laboratory discoveries with clinical applications. Topics include tumor biology, molecular genetics, immunotherapy, targeted therapies, chemotherapy, radiation oncology, surgical oncology, cancer biomarkers, and personalized medicine. The publication also highlights emerging technologies and novel therapeutic strategies designed to improve patient outcomes and quality of life. Published by Springer Nature, the journal is widely indexed in major scientific databases including PubMed, MEDLINE, Scopus, Web of Science, and Science Citation Index Expanded. As one of the established oncology journals, it maintains rigorous peer-review standards and attracts contributions from researchers worldwide. The journal continues to support the dissemination of high-quality cancer research that advances both scientific knowledge and clinical practice in oncology.

Journal of Cancer Research and Clinical Oncology (JCRCO) is :-

• International, Peer-Reviewed, Open Access, Refereed, Cancer Research, Clinical Oncology, Medical Oncology, Experimental Oncology, Tumor Biology, Cancer Diagnosis, Cancer Therapeutics, Radiation Oncology, Surgical Oncology, Immuno-Oncology, Translational Cancer Research, Molecular Oncology, Hematologic Malignancies, Precision Medicine, Cancer Prevention and Epidemiology, tumor biology, molecular genetics, immunotherapy, targeted therapies, chemotherapy, radiation oncology, surgical oncology, cancer biomarkers, personalized medicine , Online or Print , Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 0171-5216, E-ISSN: 1432-1335, Established: 1979,
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE